Testing an Anti-Inflammatory Diet for Crohn's Disease
Part of Digestive system clinical trials.
This study tests whether a specially designed anti-inflammatory American diet can help control mild to moderate Crohn's Disease symptoms. Participants will follow a diet plan, with guidance from the research team, to see if it reduces inflammation and improves quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 16 to 75 years old and have a documented diagnosis of Crohn's Disease.
- Your Crohn's should be mild to moderately active (not too severe and not in remission) with signs of inflammation.
- You must be on stable medications for Crohn's for at least 3 months.
- You cannot have ulcerative colitis, certain Crohn's complications like strictures or fistulas, or have had recent hospitalizations.
- You cannot be following a specific diet like the Specific Carbohydrate Diet, Mediterranean Diet, or anti-inflammatory diet right now.
- You cannot have celiac disease, active cancer, or other serious health conditions that could interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a tailored anti-inflammatory diet based on American foods can help people with mild to moderately active ulcerative colitis. You'll follow a special meal plan with foods like soup, smoothies, salmon, and avocado, and researchers will track your symptoms and inflammation.
This study tests whether a special diet using a nutritional supplement can reduce inflammation and improve symptoms in people with active Crohn's disease affecting the small intestine. It aims to see how the diet changes gut bacteria and body composition.
This trial studies whether eating a Mediterranean-style diet can improve inflammatory bowel disease (including mild to moderate Crohn’s). It may help by testing changes in gut inflammation measured by your symptoms and stool tests.
This study tests whether adding a special diet (called CDED) to a biologic medicine (infliximab or adalimumab) helps control Crohn's disease better than the medicine alone. It may reduce inflammation and improve symptoms.
This study tests whether a specific “exclusion diet” (removing certain foods) added to standard treatment can better control unstable Crohn’s disease in children. It may help reduce inflammation and flare-ups when symptoms are not controlled by usual medicines.
This trial tests whether a Nordic-adapted version of a special diet (called CDED) works as well as the standard version for children with Crohn's disease. It aims to help reduce inflammation and improve symptoms.
Hear when a new Crohn's Disease, Active trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.